At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 89 enrolled
Drug / intervention
Sodium fluoride +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Method Development Clinical Study Investigating the Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity
In Brief
A Phase 2 clinical trial evaluating Potassium oxalate, Sodium fluoride, and 1 other intervention for Dentin Sensitivity. Completed, enrolled 89 participants across 1 site.
Detailed Summary
To investigate the efficacy of an experimental oral rinse, containing 1.5% potassium oxalate (KOX) and 0 parts per million (ppm) fluoride in relieving dentine hypersensitivity (DH) after 8 weeks use compared with a placebo oral rinse and a commercialized fluoride oral rinse.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartAug 2017
Primary CompletionOct 2017
TodayJul 2026
First PostedAug 3, 2017
Enrollment StartAug 7, 2017
Primary CompletionOct 27, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.9 years ago
Interventions
Potassium oxalatedevice
Oral rinse containing 1.5 percent (%) KOX and 0 ppm fluoride
Sodium fluoridedrug
Oral rinse containing 0.02% weight by weight (w/w) sodium fluoride (NaF)
Placeboother
Oral rinse containing 0% KOX and 0 ppm fluoride